Fortfahren mit
Größe auswählen
| Größe/SKU | Verfügbarkeit | Preis |
|---|---|---|
200 mg | Warenkorb auf Verfügbarkeit prüfen | € 352,00 |
Über diesen Artikel
grade
pharmaceutical primary standard
agency
USP
API family
isopropamide
manufacturer/tradename
USP
application(s)
pharmaceutical
pharmaceutical (small molecule)
format
neat
SMILES string
I.CC(C)[N](C)(CCC(C(N)=O)(c1ccccc1)c2ccccc2)C(C)C
InChI
1S/C23H33N2O.HI/c1-18(2)25(5,19(3)4)17-16-23(22(24)26,20-12-8-6-9-13-20)21-14-10-7-11-15-21;/h6-15,18-19H,16-17H2,1-5H3,(H2,24,26);1H
InChI key
ZTDSVARXIUOODA-UHFFFAOYSA-N
General description
Application
Analysis Note
Other Notes
1 of 1
Dieser Artikel | |||
|---|---|---|---|
| description United States Pharmacopeia (USP) Reference Standard | description United States Pharmacopeia (USP) Reference Standard | description United States Pharmacopeia (USP) Reference Standard | description United States Pharmacopeia (USP) Reference Standard |
| grade pharmaceutical primary standard | grade pharmaceutical primary standard | grade pharmaceutical primary standard | grade pharmaceutical primary standard |
| manufacturer/tradename USP | manufacturer/tradename USP | manufacturer/tradename USP | manufacturer/tradename USP |
| format neat | format neat | format neat | format neat |
| application(s) pharmaceutical (small molecule) | application(s) pharmaceutical (small molecule) | application(s) pharmaceutical (small molecule) | application(s) pharmaceutical (small molecule) |
| API family isopropamide | API family abacavir | API family abacavir | API family abacavir |
| agency USP | agency USP | agency USP | agency USP |
Signalwort
Warning
Gefahrencodes
Sicherheitshinweise
Hazard Classifications
Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3
Zielorgane
Respiratory system
Lagerklasse
11 - Combustible Solids
Was ist los?
WGK 2
Flammpunkt (°F)
Not applicable
Flammpunkt (°C)
Not applicable
Hier finden Sie alle aktuellen Versionen:
Besitzen Sie dieses Produkt bereits?
In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.


